Cargando…

Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A

OBJECTIVE: We sought to investigate various molecular subtypes defined by genomic instability that may be related to early death and recurrence in colon cancer. METHODS: We sought to investigate various molecular subtypes defined by instability at microsatellites (MSI), changes in methylation patter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berg, Marianne, Nordgaard, Oddmund, Kørner, Hartwig, Oltedal, Satu, Smaaland, Rune, Søreide, Jon Arne, Søreide, Kjetil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399912/ https://www.ncbi.nlm.nih.gov/pubmed/25879218 http://dx.doi.org/10.1371/journal.pone.0122391

Ejemplares similares

The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
por: Oltedal, Satu, et al.
Publicado: (2018)

MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
por: Lapin, Morten, et al.
Publicado: (2017)

Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients
por: Lind, Guro E., et al.
Publicado: (2017)

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer
por: Søiland, Håvard, et al.
Publicado: (2007)

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
por: Tjensvoll, Kjersti, et al.
Publicado: (2012)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
por: Berg, Marianne, et al.
Publicado: (2011)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Long-Term Follow-Up and Survivorship After Completing Systematic Surveillance in Stage I–III Colorectal Cancer: Who Is Still at Risk?
por: Veen, T., et al.
Publicado: (2015)

Scoring systems for outcome prediction in patients with perforated peptic ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2013)

What Is the Best Predictor of Mortality in Perforated Peptic Ulcer Disease? A Population-Based, Multivariable Regression Analysis Including Three Clinical Scoring Systems
por: Thorsen, Kenneth, et al.
Publicado: (2014)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2018)

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022)

Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels
por: Berg, Marianne, et al.
Publicado: (2014)

Cell-cycle and Apoptosis Regulators (p16(INK4A), p21(CIP1), α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients
por: Soreide, Kjetil, et al.
Publicado: (2007)

Missed diagnosis of a large, right-sided diaphragmatic rupture with herniated liver and concomitant liver laceration after blunt trauma: consequences for delayed surgical repair
por: Søreide, Kjetil, et al.
Publicado: (2017)

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
por: Berg, Kaja C. G., et al.
Publicado: (2019)

Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer – the Last Clinical Frontier in Surgical Oncology?
por: Søreide, Kjetil, et al.
Publicado: (2013)

Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
por: Søreide, Kjetil, et al.
Publicado: (2020)

Observation or resection of pancreatic intraductal papillary mucinous neoplasm: An ongoing tug of war
por: Aunan, Jan Rune, et al.
Publicado: (2019)

Trends in Diagnosis and Surgical Management of Patients with Perforated Peptic Ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2011)

Primary Leiomyosarcoma of the Pancreas—a Case Report and a Comprehensive Review
por: Søreide, Jon Arne, et al.
Publicado: (2016)

Three decades (1978–2008) of Advanced Trauma Life Support (ATLS™) practice revised and evidence revisited
por: Søreide, Kjetil
Publicado: (2008)

Trauma and the acute care surgery model – should it embrace or replace general surgery?
por: Søreide, Kjetil
Publicado: (2009)

The role of high-mobility group box-1 (HMGB-1) in the management of suspected acute appendicitis: useful diagnostic biomarker or just another blind alley?
por: Søreide, Kjetil
Publicado: (2011)

Emergency surgery over 111 years: are we still at a crossroads or ready for emergency surgery 2.0?
por: Søreide, Kjetil
Publicado: (2015)

Editorial: facts, figures and the future
por: Søreide, Kjetil
Publicado: (2015)

Service as joint editor-in-chief for 11 years comes to an end: adieu, godspeed and auf wiedersehn!
por: Søreide, Kjetil
Publicado: (2015)

Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials
por: Søreide, Kjetil
Publicado: (2016)

Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?)
por: Søreide, Kjetil
Publicado: (2021)

A formula for survival in surgery
por: Søreide, Kjetil
Publicado: (2023)

Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
por: Søreide, Kjetil
Publicado: (2021)

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
por: Søreide, Kjetil, et al.
Publicado: (2014)

Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial
por: Labori, Knut Jørgen, et al.
Publicado: (2017)

Learning from experience: a qualitative study of surgeons’ perspectives on reporting and dealing with serious adverse events
por: Øyri, Sina Furnes, et al.
Publicado: (2023)

Elevated microsatellite alterations at selected tetranucleotides in early‐stage colorectal cancers with and without high‐frequency microsatellite instability: same, same but different?
por: Watson, Martin M., et al.
Publicado: (2016)

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017)

Early Surgery for Acute Cholecystitis in the Elderly: Getting it Right the First Time
por: Alshbib, Ayham, et al.
Publicado: (2023)

Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
por: Zaharia, Claudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujlvrm0b0htmlqsqu8eluijnpj